Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paravertebral Blocks in Reconstructive Breast Surgery
NCT00542542Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2007
- Primary completion
- Mar 2014
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection in breast cancer (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Proportion of Participants With No Pain Immediately After Surgery. Started Sep 2007; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00542542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00542542.